Karyotype Analysis Service Market, Global Outlook and Forecast 2022-2028

June 2022 | 67 pages | ID: K0C95F268E73EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Karyotype Analysis Service in Global, including the following market information:

Global Karyotype Analysis Service Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Karyotype Analysis Service market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

G-banding Analysis Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Karyotype Analysis Service include Thermo Fisher, Creative Bioarray, Applied StemCell, Cell Guidance Systems, KaryoLogic, Inc, Igenomix, Creative Biolabs, Bioreliance (Merck) and Labcorp, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Karyotype Analysis Service companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Karyotype Analysis Service Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Karyotype Analysis Service Market Segment Percentages, by Type, 2021 (%)

• G-banding Analysis
• Whole Genome Sequencing Analysis
• Others

Global Karyotype Analysis Service Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Karyotype Analysis Service Market Segment Percentages, by Application, 2021 (%)

• Academic and Research Institutes
• Government
• Biopharmaceutical
• Others

Global Karyotype Analysis Service Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Karyotype Analysis Service Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Karyotype Analysis Service revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Karyotype Analysis Service revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Thermo Fisher
• Creative Bioarray
• Applied StemCell
• Cell Guidance Systems
• KaryoLogic, Inc
• Igenomix
• Creative Biolabs
• Bioreliance (Merck)
• Labcorp
• Beijing Abaco Biotechnology
• Cyagen

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Karyotype Analysis Service Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Karyotype Analysis Service Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL KARYOTYPE ANALYSIS SERVICE OVERALL MARKET SIZE

2.1 Global Karyotype Analysis Service Market Size: 2021 VS 2028
2.2 Global Karyotype Analysis Service Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Karyotype Analysis Service Players in Global Market
3.2 Top Global Karyotype Analysis Service Companies Ranked by Revenue
3.3 Global Karyotype Analysis Service Revenue by Companies
3.4 Top 3 and Top 5 Karyotype Analysis Service Companies in Global Market, by Revenue in 2021
3.5 Global Companies Karyotype Analysis Service Product Type
3.6 Tier 1, Tier 2 and Tier 3 Karyotype Analysis Service Players in Global Market
  3.6.1 List of Global Tier 1 Karyotype Analysis Service Companies
  3.6.2 List of Global Tier 2 and Tier 3 Karyotype Analysis Service Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Karyotype Analysis Service Market Size Markets, 2021 & 2028
  4.1.2 G-banding Analysis
  4.1.3 Whole Genome Sequencing Analysis
  4.1.4 Others
4.2 By Type - Global Karyotype Analysis Service Revenue & Forecasts
  4.2.1 By Type - Global Karyotype Analysis Service Revenue, 2017-2022
  4.2.2 By Type - Global Karyotype Analysis Service Revenue, 2023-2028
  4.2.3 By Type - Global Karyotype Analysis Service Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Karyotype Analysis Service Market Size, 2021 & 2028
  5.1.2 Academic and Research Institutes
  5.1.3 Government
  5.1.4 Biopharmaceutical
  5.1.5 Others
5.2 By Application - Global Karyotype Analysis Service Revenue & Forecasts
  5.2.1 By Application - Global Karyotype Analysis Service Revenue, 2017-2022
  5.2.2 By Application - Global Karyotype Analysis Service Revenue, 2023-2028
  5.2.3 By Application - Global Karyotype Analysis Service Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Karyotype Analysis Service Market Size, 2021 & 2028
6.2 By Region - Global Karyotype Analysis Service Revenue & Forecasts
  6.2.1 By Region - Global Karyotype Analysis Service Revenue, 2017-2022
  6.2.2 By Region - Global Karyotype Analysis Service Revenue, 2023-2028
  6.2.3 By Region - Global Karyotype Analysis Service Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Karyotype Analysis Service Revenue, 2017-2028
  6.3.2 US Karyotype Analysis Service Market Size, 2017-2028
  6.3.3 Canada Karyotype Analysis Service Market Size, 2017-2028
  6.3.4 Mexico Karyotype Analysis Service Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Karyotype Analysis Service Revenue, 2017-2028
  6.4.2 Germany Karyotype Analysis Service Market Size, 2017-2028
  6.4.3 France Karyotype Analysis Service Market Size, 2017-2028
  6.4.4 U.K. Karyotype Analysis Service Market Size, 2017-2028
  6.4.5 Italy Karyotype Analysis Service Market Size, 2017-2028
  6.4.6 Russia Karyotype Analysis Service Market Size, 2017-2028
  6.4.7 Nordic Countries Karyotype Analysis Service Market Size, 2017-2028
  6.4.8 Benelux Karyotype Analysis Service Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Karyotype Analysis Service Revenue, 2017-2028
  6.5.2 China Karyotype Analysis Service Market Size, 2017-2028
  6.5.3 Japan Karyotype Analysis Service Market Size, 2017-2028
  6.5.4 South Korea Karyotype Analysis Service Market Size, 2017-2028
  6.5.5 Southeast Asia Karyotype Analysis Service Market Size, 2017-2028
  6.5.6 India Karyotype Analysis Service Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Karyotype Analysis Service Revenue, 2017-2028
  6.6.2 Brazil Karyotype Analysis Service Market Size, 2017-2028
  6.6.3 Argentina Karyotype Analysis Service Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Karyotype Analysis Service Revenue, 2017-2028
  6.7.2 Turkey Karyotype Analysis Service Market Size, 2017-2028
  6.7.3 Israel Karyotype Analysis Service Market Size, 2017-2028
  6.7.4 Saudi Arabia Karyotype Analysis Service Market Size, 2017-2028
  6.7.5 UAE Karyotype Analysis Service Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Thermo Fisher
  7.1.1 Thermo Fisher Corporate Summary
  7.1.2 Thermo Fisher Business Overview
  7.1.3 Thermo Fisher Karyotype Analysis Service Major Product Offerings
  7.1.4 Thermo Fisher Karyotype Analysis Service Revenue in Global Market (2017-2022)
  7.1.5 Thermo Fisher Key News
7.2 Creative Bioarray
  7.2.1 Creative Bioarray Corporate Summary
  7.2.2 Creative Bioarray Business Overview
  7.2.3 Creative Bioarray Karyotype Analysis Service Major Product Offerings
  7.2.4 Creative Bioarray Karyotype Analysis Service Revenue in Global Market (2017-2022)
  7.2.5 Creative Bioarray Key News
7.3 Applied StemCell
  7.3.1 Applied StemCell Corporate Summary
  7.3.2 Applied StemCell Business Overview
  7.3.3 Applied StemCell Karyotype Analysis Service Major Product Offerings
  7.3.4 Applied StemCell Karyotype Analysis Service Revenue in Global Market (2017-2022)
  7.3.5 Applied StemCell Key News
7.4 Cell Guidance Systems
  7.4.1 Cell Guidance Systems Corporate Summary
  7.4.2 Cell Guidance Systems Business Overview
  7.4.3 Cell Guidance Systems Karyotype Analysis Service Major Product Offerings
  7.4.4 Cell Guidance Systems Karyotype Analysis Service Revenue in Global Market (2017-2022)
  7.4.5 Cell Guidance Systems Key News
7.5 KaryoLogic, Inc
  7.5.1 KaryoLogic, Inc Corporate Summary
  7.5.2 KaryoLogic, Inc Business Overview
  7.5.3 KaryoLogic, Inc Karyotype Analysis Service Major Product Offerings
  7.5.4 KaryoLogic, Inc Karyotype Analysis Service Revenue in Global Market (2017-2022)
  7.5.5 KaryoLogic, Inc Key News
7.6 Igenomix
  7.6.1 Igenomix Corporate Summary
  7.6.2 Igenomix Business Overview
  7.6.3 Igenomix Karyotype Analysis Service Major Product Offerings
  7.6.4 Igenomix Karyotype Analysis Service Revenue in Global Market (2017-2022)
  7.6.5 Igenomix Key News
7.7 Creative Biolabs
  7.7.1 Creative Biolabs Corporate Summary
  7.7.2 Creative Biolabs Business Overview
  7.7.3 Creative Biolabs Karyotype Analysis Service Major Product Offerings
  7.7.4 Creative Biolabs Karyotype Analysis Service Revenue in Global Market (2017-2022)
  7.7.5 Creative Biolabs Key News
7.8 Bioreliance (Merck)
  7.8.1 Bioreliance (Merck) Corporate Summary
  7.8.2 Bioreliance (Merck) Business Overview
  7.8.3 Bioreliance (Merck) Karyotype Analysis Service Major Product Offerings
  7.8.4 Bioreliance (Merck) Karyotype Analysis Service Revenue in Global Market (2017-2022)
  7.8.5 Bioreliance (Merck) Key News
7.9 Labcorp
  7.9.1 Labcorp Corporate Summary
  7.9.2 Labcorp Business Overview
  7.9.3 Labcorp Karyotype Analysis Service Major Product Offerings
  7.9.4 Labcorp Karyotype Analysis Service Revenue in Global Market (2017-2022)
  7.9.5 Labcorp Key News
7.10 Beijing Abaco Biotechnology
  7.10.1 Beijing Abaco Biotechnology Corporate Summary
  7.10.2 Beijing Abaco Biotechnology Business Overview
  7.10.3 Beijing Abaco Biotechnology Karyotype Analysis Service Major Product Offerings
  7.10.4 Beijing Abaco Biotechnology Karyotype Analysis Service Revenue in Global Market (2017-2022)
  7.10.5 Beijing Abaco Biotechnology Key News
7.11 Cyagen
  7.11.1 Cyagen Corporate Summary
  7.11.2 Cyagen Business Overview
  7.11.3 Cyagen Karyotype Analysis Service Major Product Offerings
  7.11.4 Cyagen Karyotype Analysis Service Revenue in Global Market (2017-2022)
  7.11.5 Cyagen Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Karyotype Analysis Service Market Opportunities & Trends in Global Market
Table 2. Karyotype Analysis Service Market Drivers in Global Market
Table 3. Karyotype Analysis Service Market Restraints in Global Market
Table 4. Key Players of Karyotype Analysis Service in Global Market
Table 5. Top Karyotype Analysis Service Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Karyotype Analysis Service Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Karyotype Analysis Service Revenue Share by Companies, 2017-2022
Table 8. Global Companies Karyotype Analysis Service Product Type
Table 9. List of Global Tier 1 Karyotype Analysis Service Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Karyotype Analysis Service Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Karyotype Analysis Service Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Karyotype Analysis Service Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Karyotype Analysis Service Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Karyotype Analysis Service Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Karyotype Analysis Service Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Karyotype Analysis Service Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Karyotype Analysis Service Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Karyotype Analysis Service Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Karyotype Analysis Service Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Karyotype Analysis Service Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Karyotype Analysis Service Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Karyotype Analysis Service Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Karyotype Analysis Service Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Karyotype Analysis Service Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Karyotype Analysis Service Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Karyotype Analysis Service Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Karyotype Analysis Service Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Karyotype Analysis Service Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Karyotype Analysis Service Revenue, (US$, Mn), 2023-2028
Table 30. Thermo Fisher Corporate Summary
Table 31. Thermo Fisher Karyotype Analysis Service Product Offerings
Table 32. Thermo Fisher Karyotype Analysis Service Revenue (US$, Mn), (2017-2022)
Table 33. Creative Bioarray Corporate Summary
Table 34. Creative Bioarray Karyotype Analysis Service Product Offerings
Table 35. Creative Bioarray Karyotype Analysis Service Revenue (US$, Mn), (2017-2022)
Table 36. Applied StemCell Corporate Summary
Table 37. Applied StemCell Karyotype Analysis Service Product Offerings
Table 38. Applied StemCell Karyotype Analysis Service Revenue (US$, Mn), (2017-2022)
Table 39. Cell Guidance Systems Corporate Summary
Table 40. Cell Guidance Systems Karyotype Analysis Service Product Offerings
Table 41. Cell Guidance Systems Karyotype Analysis Service Revenue (US$, Mn), (2017-2022)
Table 42. KaryoLogic, Inc Corporate Summary
Table 43. KaryoLogic, Inc Karyotype Analysis Service Product Offerings
Table 44. KaryoLogic, Inc Karyotype Analysis Service Revenue (US$, Mn), (2017-2022)
Table 45. Igenomix Corporate Summary
Table 46. Igenomix Karyotype Analysis Service Product Offerings
Table 47. Igenomix Karyotype Analysis Service Revenue (US$, Mn), (2017-2022)
Table 48. Creative Biolabs Corporate Summary
Table 49. Creative Biolabs Karyotype Analysis Service Product Offerings
Table 50. Creative Biolabs Karyotype Analysis Service Revenue (US$, Mn), (2017-2022)
Table 51. Bioreliance (Merck) Corporate Summary
Table 52. Bioreliance (Merck) Karyotype Analysis Service Product Offerings
Table 53. Bioreliance (Merck) Karyotype Analysis Service Revenue (US$, Mn), (2017-2022)
Table 54. Labcorp Corporate Summary
Table 55. Labcorp Karyotype Analysis Service Product Offerings
Table 56. Labcorp Karyotype Analysis Service Revenue (US$, Mn), (2017-2022)
Table 57. Beijing Abaco Biotechnology Corporate Summary
Table 58. Beijing Abaco Biotechnology Karyotype Analysis Service Product Offerings
Table 59. Beijing Abaco Biotechnology Karyotype Analysis Service Revenue (US$, Mn), (2017-2022)
Table 60. Cyagen Corporate Summary
Table 61. Cyagen Karyotype Analysis Service Product Offerings
Table 62. Cyagen Karyotype Analysis Service Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Karyotype Analysis Service Segment by Type in 2021
Figure 2. Karyotype Analysis Service Segment by Application in 2021
Figure 3. Global Karyotype Analysis Service Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Karyotype Analysis Service Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Karyotype Analysis Service Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Karyotype Analysis Service Revenue in 2021
Figure 8. By Type - Global Karyotype Analysis Service Revenue Market Share, 2017-2028
Figure 9. By Application - Global Karyotype Analysis Service Revenue Market Share, 2017-2028
Figure 10. By Region - Global Karyotype Analysis Service Revenue Market Share, 2017-2028
Figure 11. By Country - North America Karyotype Analysis Service Revenue Market Share, 2017-2028
Figure 12. US Karyotype Analysis Service Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Karyotype Analysis Service Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Karyotype Analysis Service Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Karyotype Analysis Service Revenue Market Share, 2017-2028
Figure 16. Germany Karyotype Analysis Service Revenue, (US$, Mn), 2017-2028
Figure 17. France Karyotype Analysis Service Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Karyotype Analysis Service Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Karyotype Analysis Service Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Karyotype Analysis Service Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Karyotype Analysis Service Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Karyotype Analysis Service Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Karyotype Analysis Service Revenue Market Share, 2017-2028
Figure 24. China Karyotype Analysis Service Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Karyotype Analysis Service Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Karyotype Analysis Service Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Karyotype Analysis Service Revenue, (US$, Mn), 2017-2028
Figure 28. India Karyotype Analysis Service Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Karyotype Analysis Service Revenue Market Share, 2017-2028
Figure 30. Brazil Karyotype Analysis Service Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Karyotype Analysis Service Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Karyotype Analysis Service Revenue Market Share, 2017-2028
Figure 33. Turkey Karyotype Analysis Service Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Karyotype Analysis Service Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Karyotype Analysis Service Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Karyotype Analysis Service Revenue, (US$, Mn), 2017-2028
Figure 37. Thermo Fisher Karyotype Analysis Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Creative Bioarray Karyotype Analysis Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Applied StemCell Karyotype Analysis Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Cell Guidance Systems Karyotype Analysis Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. KaryoLogic, Inc Karyotype Analysis Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Igenomix Karyotype Analysis Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Creative Biolabs Karyotype Analysis Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bioreliance (Merck) Karyotype Analysis Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Labcorp Karyotype Analysis Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Beijing Abaco Biotechnology Karyotype Analysis Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Cyagen Karyotype Analysis Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)